Functionalized gold nanoparticles (AuNPs) are widely
used in therapeutic
applications, but little is known regarding the impact of their surface
functionalization in the process of toxicity against cancer cells.
This study investigates the anticancer effects of 5 nm spherical AuNPs
functionalized with tannate, citrate, and PVP on deubiquitinating
enzymes (DUBs) in human lung alveolar adenocarcinoma (A549) cells.
Our findings show that functionalized AuNPs reduce the cell viability
in a concentration- and time-dependent manner as measured by modified
lactate dehydrogenase (mLDH) and 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) assays. An increased generation of intracellular reactive
oxygen species (ROS) and depletion of glutathione (GSH/GSSG) ratio
was observed with the highest AuNP concentration of 10 μg/mL.
The expression of DUBs such as ubiquitin specific proteases (USP7,
USP8, and USP10) was slightly inhibited when treated with concentrations
above 2.5 μg/mL. Moreover, functionalized AuNPs showed an inhibitory
effect on protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR)
and wingless-related integration site (Wnt) signaling proteins, and
this could further trigger mitochondrial related-apoptosis by the
upregulation of caspase-3, caspase-9, and PARP in A549 cells. Furthermore,
our study shows a mechanistic understanding of how functionalized
AuNPs inhibit the DUBs, consequently suppressing cell proliferation,
and can be modulated as an approach toward anticancer therapy. The
study also warrants the need for future work to investigate the effect
of functionalized AuNPs on DUB on other cancer cell lines both in
vitro and in vivo.